Benzinga's Top Initiations By: Benzinga via Benzinga September 08, 2015 at 09:29 AM EDT Analysts at H.C. Wainwright initiated coverage on CymaBay Therapeutics Inc (NASDAQ: CBAY) with a Buy rating. The target price for ... Read More >> Related Stocks: Aldeyra Therapeu Bluebird Bio Cymabay Therapeutics Del Taco Rest Facebook Global Blood Ther Houlihan Lokey NetApp